{"id":4209,"date":"2024-03-11T19:21:08","date_gmt":"2024-03-11T22:21:08","guid":{"rendered":"https:\/\/rededor2023.blendon.com.br\/capital-intelectual\/instituto-dor-de-pesquisa-e-ensino-idor\/"},"modified":"2024-07-11T14:46:51","modified_gmt":"2024-07-11T17:46:51","slug":"dor-institute-for-research-and-education-idor","status":"publish","type":"page","link":"https:\/\/rededor2023.blendon.com.br\/en\/intellectual-capital\/dor-institute-for-research-and-education-idor\/","title":{"rendered":"D\u2019Or Institute for Research and Education - IDOR"},"content":{"rendered":"\n

Intellectual capital highlights <\/h2>\n\n\n\n

GRI 3-3<\/p>\n\n\n

\n\n
\n
\"\"<\/figure><\/div><\/div><\/div>\n\n\n\n
\n\n
\n
\"\"<\/figure>\n\n\n\n

EW MOLECULAR PATHOLOGY
BRL 80 million invested in facilities and equipment<\/mark><\/p>\n<\/div><\/div>\n\n\n\n

\n
<\/div><\/div>\n\n\n\n

ARTICLES PUBLISHED IN 2023, leading
324 citations<\/mark><\/p>\n<\/div><\/div>\n\n\n\n

\n
<\/div><\/div>\n\n\n\n

million, in partnership agreements through Open D\u2019Or<\/mark><\/p>\n<\/div><\/div>\n\n\n\n

\n
<\/div><\/div>\n\n\n\n

FIELDS
Research line covering<\/mark><\/p>\n<\/div><\/div>\n\n<\/div><\/div><\/div><\/div>\n\n<\/div><\/div>\n\n\n

<\/div>\n\n\n
\n\n
\n

We are the main sponsors of D\u2019Or Institute for Research and Education<\/strong><\/a> (Instituto D\u2019Or de Pesquisa e Ensino <\/em>- IDOR, in Portuguese), a non-profit organization that contributes to the advancement of science, aiming to improve human life conditions. As such, the Institute brings together a body of researchers from different backgrounds to develop cutting-edge research and new technologies in the healthcare field.<\/p>\n\n\n\n

Since its foundation in 2010, IDOR has been consistently contributing to national and international public health\u2014such as in understanding the role of the Zika virus in nervous system malformation and in research aimed at fighting the Covid-19 pandemic, conducting drug clinical trials and monitoring volunteers (over 6,000 in total) for the Oxford\/AstraZeneca study in Brazil and subsequently for the Coronavac\/Butantan and Clover vaccines. In addition to its headquarters in Botafogo, the Institute boasts extensive facilities within Hospital Gl\u00f3ria D\u2019Or, dedicated to clinical research and educational purposes. It also has units in S\u00e3o Paulo (SP), Salvador (BA) and Bras\u00edlia (DF), which operate together in research, education and innovation. IDOR extends its research to other Brazilian capitals, benefiting from Rede D\u2019Or\u2019s structure in this process.<\/p>\n<\/div><\/div>\n\n\n\n

\n\n
\n
\n
<\/div><\/div>\n\n\n\n

International Collaborations<\/strong><\/p>\n\n\n\n

in scientific publications<\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n

\n
\n
<\/div><\/div>\n\n\n\n

Publications<\/strong><\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n

\n
\n
<\/div><\/div>\n\n\n\n

Citations<\/strong><\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n

\n
\n

Collaboration in<\/p>\n\n\n\n

<\/div><\/div>\n\n\n\n

Countries<\/strong><\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n<\/div><\/div>\n\n\n

\n

International partnerships with the highest number of publications: Monash University (Australia), King\u2019s College (England), Oxford (England), Harvard (United States) and the National Institute of Health and Medical Research - Inserm (France).<\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n<\/div><\/div>\n\n\n

*IDOR figures since 2010.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Production and research<\/h2>\n\n\n\n

GRI 203-2<\/p>\n\n\n\n

The outstanding research conducted at IDOR has resulted in around two thousand publications since 2010, which have received over 39,000 citations in highly prestigious scientific journals. During this same period, we have established international scientific partnerships in over 80 countries. Among the studies published, 160 were dedicated to Covid-19 between 2020 and 2023. These figures underscore the strong dedication to science that we uphold at IDOR. In 2023 alone, scientists at IDOR published 192 new articles, resulting in 324 citations. The increasing number of impactful publications is matter of pride for everyone involved.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n \n\n \n \n \n \n
\n <\/th>\n \n 2023 <\/th>\n \n 2022 <\/th>\n <\/tr>\n
\n Number of articles published <\/td>\n \n 192 <\/td>\n \n 236 <\/td>\n <\/tr>\n
\n Number of citations <\/td>\n \n 324 <\/td>\n \n 299 <\/td>\n <\/tr>\n
\n Number or researchers <\/td>\n \n 123 <\/td>\n \n +100 <\/td>\n <\/tr>\n <\/table>\n<\/div>